Articles - 2h4g mentioned but not cited (1)
- research-article Native dynamics and allosteric responses in PTP1B probed by high-resolution HDX-MS. Woods VA, Abzalimov RR, Keedy DA. bioRxiv 2023.07.12.548582 (2023)
Reviews citing this publication (7)
- The therapeutic potential of phosphatase inhibitors. Vintonyak VV, Antonchick AP, Rauh D, Waldmann H. Curr Opin Chem Biol 13 272-283 (2009)
- Recent and emerging anti-diabetes targets. Mohler ML, He Y, Wu Z, Hwang DJ, Miller DD. Med Res Rev 29 125-195 (2009)
- PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II. Eleftheriou P, Geronikaki A, Petrou A. Curr Top Med Chem 19 246-263 (2019)
- Bidentate inhibitors of protein tyrosine phosphatases. Low JL, Chai CL, Yao SQ. Antioxid Redox Signal 20 2225-2250 (2014)
- Phosphotyrosine isosteres: past, present and future. Cerulli RA, Kritzer JA. Org Biomol Chem 18 583-605 (2020)
- Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century. Campos-Almazán MI, Hernández-Campos A, Castillo R, Sierra-Campos E, Valdez-Solana M, Avitia-Domínguez C, Téllez-Valencia A. Pharmaceuticals (Basel) 15 866 (2022)
- The development of protein tyrosine phosphatase1B inhibitors defined by binding sites in crystalline complexes. Zhang Y, Du Y. Future Med Chem 10 2345-2367 (2018)